Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs LevelsRx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and LevelsRx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 288 · Grade C

LevelsRx

Visit LevelsRx Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 64 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make LevelsRx a bad call — it's best for people seeking support alongside compounded injections who can confirm the renewal price, phone cancellation process and guarantee requirements. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
71
Transparency
90
72
Access Breadth
93
56
Clinical Oversight
92
76
Track Record
88
65
CoreAge RxBrief Score 94 · 64LevelsRx

Price, coverage & the tracker

CoreAge RxLevelsRx
Brief Score94/100 (A)64/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

From $129 first month; renewal unconfirmed

Compounded weekly injection; advertised medication, supplies, coaching and delivery included. Complete continuing-plan and selected-dose charge unconfirmed.

Cancel by phone at least seven days before billing. Conditional six-month medication-fee guarantee excludes coaching; damaged/incorrect shipment reports due within 24 hours.

Full price details

Compounded semaglutide weekly injection offered; complete continuing-plan quote unknown; from $129 first month with medication, supplies, coaching and delivery advertised, renewal amount unconfirmed

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

From $169 first month; renewal unconfirmed

Compounded weekly injection; advertised medication, supplies, coaching and delivery included. Complete continuing-plan and selected-dose charge unconfirmed.

Cancel by phone at least seven days before billing. Conditional six-month medication-fee guarantee excludes coaching; damaged/incorrect shipment reports due within 24 hours.

Full price details

Compounded tirzepatide weekly injection offered; complete continuing-plan quote unknown; from $169 first month with medication, supplies, coaching and delivery advertised, renewal amount unconfirmed

CoverageUS only; restrictions by state, confirmed at intakeMost U.S. states advertised; the selected clinician, pharmacy and patient-state eligibility require confirmation
Brand-name accessNot confirmedThe reviewed current treatment offer is compounded; brand-name trial discussion does not establish a branded prescription offer.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

LevelsRx: First month from $129 semaglutide/$169 tirzepatide; renewal quote unconfirmed. Phone cancellation needs seven days notice. Conditional six-month guarantee excludes coaching; damage reports due within 24 hours.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.